UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Regulation and function of interleukin‐36 cytokines in homeostasis and pathological conditions

Journal of leukocyte biology, 2015-04, Vol.97 (4), p.645-652

2015

Volltextzugriff (PDF)

Regulation and function of interleukin‐36 cytokines

Immunological reviews, 2018-01, Vol.281 (1), p.169-178

2018

Volltextzugriff (PDF)

The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings

Journal of investigative dermatology, 2013-01, Vol.133 (1), p.17-26

2013

Volltextzugriff (PDF)

Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation

Immunity (Cambridge, Mass.), 2015-10, Vol.43 (4), p.739-750

2015

Volltextzugriff (PDF)

Differing roles for short chain fatty acids and GPR43 agonism in the regulation of intestinal barrier function and immune responses

PloS one, 2017-07, Vol.12 (7), p.e0180190-e0180190

2017

Volltextzugriff (PDF)

The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses

Trends in immunology, 2013-04, Vol.34 (4), p.174-181

2013

Volltextzugriff (PDF)

QRICH1 dictates the outcome of ER stress through transcriptional control of proteostasis

Science (American Association for the Advancement of Science), 2021-01, Vol.371 (6524)

2021

Volltextzugriff (PDF)

Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36α, IL-36β, and IL-36γ) or Antagonist (IL-36Ra) Activity

The Journal of biological chemistry, 2011-12, Vol.286 (49), p.42594-42602

2011

Volltextzugriff (PDF)

Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage

The Journal of immunology (1950), 2016-01, Vol.196 (1), p.34-38

2016

Volltextzugriff (PDF)

IL-1RL2 and its ligands contribute to the cytokine network in psoriasis

The Journal of immunology (1950), 2010-10, Vol.185 (7), p.4354-4362

2010

Volltextzugriff (PDF)

Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation

The Journal of experimental medicine, 2007-10, Vol.204 (11), p.2603-2614

2007

Volltextzugriff (PDF)

Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State

Cancer research (Chicago, Ill.), 2012-08, Vol.72 (16), p.3987-3996

2012

Volltextzugriff (PDF)

The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced inflammatory macrophage recruitment to the intestinal mucosa and suppressed murine T cell mediated colitis

PloS one, 2019-11, Vol.14 (11), p.e0223918-e0223918

2019

Volltextzugriff (PDF)

The severity of experimental arthritis is independent of IL-36 receptor signaling

Arthritis research & therapy, 2013-03, Vol.15 (2), p.R38-R38, Article R38

2013

Volltextzugriff (PDF)

Combined Anti-CD40 and Anti-IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases

Cancer research (Chicago, Ill.), 2014-05, Vol.74 (9), p.2412-2421

2014

Volltextzugriff (PDF)

Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions

Cytokine (Philadelphia, Pa.), 2022-08, Vol.156, p.155897-155897, Article 155897

2022

Volltextzugriff (PDF)

Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis

The New England journal of medicine, 2011-08, Vol.365 (7), p.620-628

2011

Volltextzugriff (PDF)

Abnormal Small Intestinal Epithelial Microvilli in Patients With Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2018-09, Vol.155 (3), p.815-828

2018

Volltextzugriff (PDF)

A Role for IL-12 in IBD after All?

Immunity (Cambridge, Mass.), 2019-08, Vol.51 (2), p.209-211

2019

Volltextzugriff (PDF)

Decreased Expression of Aquaporin (AQP)1 and AQP5 in Mouse Lung after Acute Viral Infection

American journal of respiratory cell and molecular biology, 2000-01, Vol.22 (1), p.34-44

2000

Volltextzugriff (PDF)

Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases

Rheumatology (Oxford, England), 2016-12, Vol.55 (suppl 2), p.ii43-ii55

2016

Volltextzugriff (PDF)

Get the IL-17F outta here

Nature immunology, 2018-07, Vol.19 (7), p.648-650

2018

Volltextzugriff (PDF)

Identification of highly selective SIK1/2 inhibitors that modulate innate immune activation and suppress intestinal inflammation

Proceedings of the National Academy of Sciences - PNAS, 2024-01, Vol.121 (1), p.e2307086120

2024

Volltextzugriff (PDF)

Mutation in IL36RN impairs the processing and regulatory function of the interleukin‐36‐receptor antagonist and is associated with DITRA syndrome

Experimental dermatology, 2019-10, Vol.28 (10), p.1114-1117

2019

Volltextzugriff (PDF)

Publisher Correction: Get the IL-17F outta here

Nature immunology, 2019-03, Vol.20 (3), p.374-374

2019

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(61)
Berichte
(1)

Sprache

Englisch
(62)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Regulation and function of interleukin‐36 cytokines in homeostasis and pathological conditions

Regulation and function of interleukin‐36 cytokines

The Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings

Differential Roles for Interleukin-23 and Interleukin-17 in Intestinal Immunoregulation

Differing roles for short chain fatty acids and GPR43 agonism in the regulation of intestinal barrier function and immune responses

The IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses

QRICH1 dictates the outcome of ER stress through transcriptional control of proteostasis

Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36α, IL-36β, and IL-36γ) or Antagonist (IL-36Ra) Activity

Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage

IL-1RL2 and its ligands contribute to the cytokine network in psoriasis

Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation

Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State

The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced inflammatory macrophage recruitment to the intestinal mucosa and suppressed murine T cell mediated colitis

The severity of experimental arthritis is independent of IL-36 receptor signaling

Combined Anti-CD40 and Anti-IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases

Role of IL-36 cytokines in psoriasis and other inflammatory skin conditions

Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis

Abnormal Small Intestinal Epithelial Microvilli in Patients With Crohn's Disease

A Role for IL-12 in IBD after All?

Decreased Expression of Aquaporin (AQP)1 and AQP5 in Mouse Lung after Acute Viral Infection

Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases

Get the IL-17F outta here

Identification of highly selective SIK1/2 inhibitors that modulate innate immune activation and suppress intestinal inflammation

Mutation in IL36RN impairs the processing and regulatory function of the interleukin‐36‐receptor antagonist and is associated with DITRA syndrome

Publisher Correction: Get the IL-17F outta here

Suchergebnisse filtern